"Designing Growth Strategies is in our DNA"

Africa Clinical Trials Market Size, Share & Industry Analysis, By Phase (Phase I, Phase II, Phase III, and Phase IV), By Application (Oncology, CNS Disorder, Cardiology, Infectious Disease, Metabolic Disorder, Renal/Nephrology, and Others), and Regional Forecast, 2024-2032

Last Updated: February 10, 2025 | Format: PDF | Report ID: FBI110939

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Number of Clinical Trials Registered – by Key Countries, 2022
    2. Total R&D Expenditure - by Key Players
    3. Overview of Regulatory Scenario - by Key Countries/Region
    4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
    5. Impact of COVID-19 on the Market
  5. Africa Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. CNS Disorder
      3. Cardiology
      4. Infectious Disease
      5. Metabolic Disorder
      6. Renal/Nephrology
      7. Others
    3. Market Analysis, Insights and Forecast – By Region
      1. West Africa
      2. Central Africa
      3. East Africa
      4. South Africa
  6. West Africa Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. CNS Disorder
      3. Cardiology
      4. Infectious Disease
      5. Metabolic Disorder
      6. Renal/Nephrology
      7. Others
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Senegal
      2. Mali
      3. Burkina Faso
      4. Cote d’Ivoire
      5. Ghana
      6. Gambia
      7. Nigeria
      8. Rest of West Africa
    4. Senegal Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
      1. Market Analysis, Insights and Forecast – By Phase
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. Market Analysis, Insights and Forecast – By Application
        1. Oncology
        2. CNS Disorder
        3. Cardiology
        4. Infectious Disease
        5. Metabolic Disorder
        6. Renal/Nephrology
        7. Others
    5. Mali Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
      1. Market Analysis, Insights and Forecast – By Phase
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. Market Analysis, Insights and Forecast – By Application
        1. Oncology
        2. CNS Disorder
        3. Cardiology
        4. Infectious Disease
        5. Metabolic Disorder
        6. Renal/Nephrology
        7. Others
    6. Burkina Faso Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
      1. Market Analysis, Insights and Forecast – By Phase
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. Market Analysis, Insights and Forecast – By Application
        1. Oncology
        2. CNS Disorder
        3. Cardiology
        4. Infectious Disease
        5. Metabolic Disorder
        6. Renal/Nephrology
        7. Others
    7. Cote d’Ivoire Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
      1. Market Analysis, Insights and Forecast – By Phase
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. Market Analysis, Insights and Forecast – By Application
        1. Oncology
        2. CNS Disorder
        3. Cardiology
        4. Infectious Disease
        5. Metabolic Disorder
        6. Renal/Nephrology
        7. Others
    8. Ghana Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
      1. Market Analysis, Insights and Forecast – By Phase
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. Market Analysis, Insights and Forecast – By Application
        1. Oncology
        2. CNS Disorder
        3. Cardiology
        4. Infectious Disease
        5. Metabolic Disorder
        6. Renal/Nephrology
        7. Others
    9. Gambia Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
      1. Market Analysis, Insights and Forecast – By Phase
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. Market Analysis, Insights and Forecast – By Application
        1. Oncology
        2. CNS Disorder
        3. Cardiology
        4. Infectious Disease
        5. Metabolic Disorder
        6. Renal/Nephrology
        7. Others
    10. Nigeria Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
      1. Market Analysis, Insights and Forecast – By Phase
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. Market Analysis, Insights and Forecast – By Application
        1. Oncology
        2. CNS Disorder
        3. Cardiology
        4. Infectious Disease
        5. Metabolic Disorder
        6. Renal/Nephrology
        7. Others
    11. Rest of West Africa Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
      1. Market Analysis, Insights and Forecast – By Phase
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. Market Analysis, Insights and Forecast – By Application
        1. Oncology
        2. CNS Disorder
        3. Cardiology
        4. Infectious Disease
        5. Metabolic Disorder
        6. Renal/Nephrology
        7. Others
  7. Central Africa Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. CNS Disorder
      3. Cardiology
      4. Infectious Disease
      5. Metabolic Disorder
      6. Renal/Nephrology
      7. Others
    3. Market Analysis, Insights and Forecast – By Region
      1. Cameroon
      2. Congo & DRC
      3. Gabon
      4. Republic of Central Africa
      5. Rest of Central Africa
    4. Cameroon Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
      1. Market Analysis, Insights and Forecast – By Phase
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. Market Analysis, Insights and Forecast – By Application
        1. Oncology
        2. CNS Disorder
        3. Cardiology
        4. Infectious Disease
        5. Metabolic Disorder
        6. Renal/Nephrology
        7. Others
    5. Congo & DRC Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
      1. Market Analysis, Insights and Forecast – By Phase
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. Market Analysis, Insights and Forecast – By Application
        1. Oncology
        2. CNS Disorder
        3. Cardiology
        4. Infectious Disease
        5. Metabolic Disorder
        6. Renal/Nephrology
        7. Others
    6. Gabon Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
      1. Market Analysis, Insights and Forecast – By Phase
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. Market Analysis, Insights and Forecast – By Application
        1. Oncology
        2. CNS Disorder
        3. Cardiology
        4. Infectious Disease
        5. Metabolic Disorder
        6. Renal/Nephrology
        7. Others
    7. Reublic of Central Africa Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
      1. Market Analysis, Insights and Forecast – By Phase
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. Market Analysis, Insights and Forecast – By Application
        1. Oncology
        2. CNS Disorder
        3. Cardiology
        4. Infectious Disease
        5. Metabolic Disorder
        6. Renal/Nephrology
        7. Others
    8. Rest of Central Africa Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
      1. Market Analysis, Insights and Forecast – By Phase
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. Market Analysis, Insights and Forecast – By Application
        1. Oncology
        2. CNS Disorder
        3. Cardiology
        4. Infectious Disease
        5. Metabolic Disorder
        6. Renal/Nephrology
        7. Others
  8. East Africa Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. CNS Disorder
      3. Cardiology
      4. Infectious Disease
      5. Metabolic Disorder
      6. Renal/Nephrology
      7. Others
    3. Market Analysis, Insights and Forecast – By Region
      1. Kenya
      2. Uganda
      3. Tanzania
      4. Rest of East Africa
    4. Kenya Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
      1. Market Analysis, Insights and Forecast – By Phase
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. Market Analysis, Insights and Forecast – By Application
        1. Oncology
        2. CNS Disorder
        3. Cardiology
        4. Infectious Disease
        5. Metabolic Disorder
        6. Renal/Nephrology
        7. Others
    5. Uganda Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
      1. Market Analysis, Insights and Forecast – By Phase
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. Market Analysis, Insights and Forecast – By Application
        1. Oncology
        2. CNS Disorder
        3. Cardiology
        4. Infectious Disease
        5. Metabolic Disorder
        6. Renal/Nephrology
        7. Others
    6. Tanzania Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
      1. Market Analysis, Insights and Forecast – By Phase
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. Market Analysis, Insights and Forecast – By Application
        1. Oncology
        2. CNS Disorder
        3. Cardiology
        4. Infectious Disease
        5. Metabolic Disorder
        6. Renal/Nephrology
        7. Others
    7. Rest of East Africa Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
      1. Market Analysis, Insights and Forecast – By Phase
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. Market Analysis, Insights and Forecast – By Application
        1. Oncology
        2. CNS Disorder
        3. Cardiology
        4. Infectious Disease
        5. Metabolic Disorder
        6. Renal/Nephrology
        7. Others
  9. South Africa Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. CNS Disorder
      3. Cardiology
      4. Infectious Disease
      5. Metabolic Disorder
      6. Renal/Nephrology
      7. Others
    3. Market Analysis, Insights and Forecast – By Region
      1. Angola
      2. South Africa
      3. Mozambique
      4. Rest of South Africa
    4. Angola Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
      1. Market Analysis, Insights and Forecast – By Phase
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. Market Analysis, Insights and Forecast – By Application
        1. Oncology
        2. CNS Disorder
        3. Cardiology
        4. Infectious Disease
        5. Metabolic Disorder
        6. Renal/Nephrology
        7. Others
    5. South Africa Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
      1. Market Analysis, Insights and Forecast – By Phase
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. Market Analysis, Insights and Forecast – By Application
        1. Oncology
        2. CNS Disorder
        3. Cardiology
        4. Infectious Disease
        5. Metabolic Disorder
        6. Renal/Nephrology
        7. Others
    6. Mozambique Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
      1. Market Analysis, Insights and Forecast – By Phase
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. Market Analysis, Insights and Forecast – By Application
        1. Oncology
        2. CNS Disorder
        3. Cardiology
        4. Infectious Disease
        5. Metabolic Disorder
        6. Renal/Nephrology
        7. Others
    7. Rest of South Africa Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
      1. Market Analysis, Insights and Forecast – By Phase
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. Market Analysis, Insights and Forecast – By Application
        1. Oncology
        2. CNS Disorder
        3. Cardiology
        4. Infectious Disease
        5. Metabolic Disorder
        6. Renal/Nephrology
        7. Others
  10. Competitive Analysis
    1. Leading Players: Africa Clinical Trials Market, 2023
    2. Company Profiles
      1. IQVIA Inc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      2. ICON plc
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Syneos Health
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Laboratory Corporation of America Holdings
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Medpace Holdings, Inc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Charles River Laboratories
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Novotech
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Parexel International Corporation
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Pharmalys
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 01: Africa Clinical Trials Market Revenue Breakdown (USD billion, %) by Region, 2023 & 2032

Figure 02: Africa Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 03: Africa Clinical Trials Market Value Share (%), by Phase, 2023

Figure 04: Africa Clinical Trials Market Value (USD billion), by Application, 2023 & 2032

Figure 05: Africa Clinical Trials Market Value Share (%), by Application, 2023

Figure 06: Africa Clinical Trials Market Value (USD billion), by Region, 2023 & 2032

Figure 07: Africa Clinical Trials Market Value Share (%), by Region, 2023

Figure 08: West Africa Clinical Trials Market Value (USD billion), by Country/Sub-region, 2023 & 2032

Figure 09: West Africa Clinical Trials Market Value Share (%), by Country/Sub-region, 2023

Figure 10: West Africa Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 11: West Africa Clinical Trials Market Value Share (%), by Phase, 2023

Figure 12: West Africa Clinical Trials Market Value (USD billion), by Application, 2023 & 2032

Figure 13: West Africa Clinical Trials Market Value Share (%), by Application, 2023

Figure 14: Senegal Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 15: Senegal Clinical Trials Market Value Share (%), by Phase, 2023

Figure 16: Senegal Clinical Trials Market Value Share (%), by Application, 2023

Figure 17: Mali Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 18: Mali Clinical Trials Market Value Share (%), by Phase, 2023

Figure 19: Mali Clinical Trials Market Value Share (%), by Application, 2023

Figure 20: Burkina Faso Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 21: Burkina Faso Clinical Trials Market Value Share (%), by Phase, 2023

Figure 22: Burkina Faso Clinical Trials Market Value Share (%), by Application, 2023

Figure 23: Cote d’Ivoire Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 24: Cote d’Ivoire Clinical Trials Market Value Share (%), by Phase, 2023

Figure 25: Cote d’Ivoire Clinical Trials Market Value Share (%), by Application, 2023

Figure 26: Ghana Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 27: Ghana Clinical Trials Market Value Share (%), by Phase, 2023

Figure 28: Ghana Clinical Trials Market Value Share (%), by Application, 2023

Figure 29: Gambia Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 30: Gambia Clinical Trials Market Value Share (%), by Phase, 2023

Figure 31: Gambia Clinical Trials Market Value Share (%), by Application, 2023

Figure 32: Nigeria Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 33: Nigeria Clinical Trials Market Value Share (%), by Phase, 2023

Figure 34: Nigeria Clinical Trials Market Value Share (%), by Application, 2023

Figure 35: Rest of West Africa Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 36: Rest of West Africa Clinical Trials Market Value Share (%), by Phase, 2023

Figure 37: Rest of West Africa Clinical Trials Market Value Share (%), by Application, 2023

Figure 38: Central Africa Clinical Trials Market Value (USD billion), by Country/Sub-region, 2023 & 2032

Figure 39: Central Africa Clinical Trials Market Value Share (%), by Country/Sub-region, 2023

Figure 40: Central Africa Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 41: Central Africa Clinical Trials Market Value Share (%), by Phase, 2023

Figure 42: Central Africa Clinical Trials Market Value (USD billion), by Application, 2023 & 2032

Figure 43: Central Africa Clinical Trials Market Value Share (%), by Application, 2023

Figure 44: Cameroon Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 45: Cameroon Clinical Trials Market Value Share (%), by Phase, 2023

Figure 46: Cameroon Clinical Trials Market Value Share (%), by Application, 2023

Figure 47: Congo & DRC Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 48: Congo & DRC Clinical Trials Market Value Share (%), by Phase, 2023

Figure 49: Congo & DRC Clinical Trials Market Value Share (%), by Application, 2023

Figure 50: Gabon Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 51: Gabon Clinical Trials Market Value Share (%), by Phase, 2023

Figure 52: Gabon Clinical Trials Market Value Share (%), by Application, 2023

Figure 53: Republic of Central Africa Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 54: Republic of Central Africa Clinical Trials Market Value Share (%), by Phase, 2023

Figure 55: Republic of Central Africa Clinical Trials Market Value Share (%), by Application, 2023

Figure 56: Rest of Central Africa Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 57: Rest of Central Africa Clinical Trials Market Value Share (%), by Phase, 2023

Figure 58: Rest of Central Africa Clinical Trials Market Value Share (%), by Application, 2023

Figure 59: East Africa Clinical Trials Market Value (USD billion), by Country/Sub-region, 2023 & 2032

Figure 60: East Africa Clinical Trials Market Value Share (%), by Country/Sub-region, 2023

Figure 61: East Africa Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 62: East Africa Clinical Trials Market Value Share (%), by Phase, 2023

Figure 63: East Africa Clinical Trials Market Value (USD billion), by Application, 2023 & 2032

Figure 64: East Africa Clinical Trials Market Value Share (%), by Application, 2023

Figure 65: Kenya Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 66: Kenya Clinical Trials Market Value Share (%), by Phase, 2023

Figure 67: Kenya Clinical Trials Market Value Share (%), by Application, 2023

Figure 68: Uganda Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 69: Uganda Clinical Trials Market Value Share (%), by Phase, 2023

Figure 70: Uganda Clinical Trials Market Value Share (%), by Application, 2023

Figure 71: Tanzania Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 72: Tanzania Clinical Trials Market Value Share (%), by Phase, 2023

Figure 73: Tanzania Clinical Trials Market Value Share (%), by Application, 2023

Figure 74: Rest of East Africa Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 75: Rest of East Africa Clinical Trials Market Value Share (%), by Phase, 2023

Figure 76: Rest of East Africa Clinical Trials Market Value Share (%), by Application, 2023

Figure 77: South Africa Clinical Trials Market Value (USD billion), by Country/Sub-region, 2023 & 2032

Figure 78: South Africa Clinical Trials Market Value Share (%), by Country/Sub-region, 2023

Figure 79: South Africa Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 80: South Africa Clinical Trials Market Value Share (%), by Phase, 2023

Figure 81: South Africa Clinical Trials Market Value (USD billion), by Application, 2023 & 2032

Figure 83: Angola Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 84: Angola Clinical Trials Market Value Share (%), by Phase, 2023

Figure 85: Angola Clinical Trials Market Value Share (%), by Application, 2023

Figure 86: South Africa Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 87: South Africa Clinical Trials Market Value Share (%), by Phase, 2023

Figure 88: South Africa Clinical Trials Market Value Share (%), by Application, 2023

Figure 89: Mozambique Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 90: Mozambique Clinical Trials Market Value Share (%), by Phase, 2023

Figure 91: Mozambique Clinical Trials Market Value Share (%), by Application, 2023

Figure 92: Rest of South Africa Clinical Trials Market Value (USD billion), by Phase, 2023 & 2032

Figure 93: Rest of South Africa Clinical Trials Market Value Share (%), by Phase, 2023

Figure 94: Rest of South Africa Clinical Trials Market Value Share (%), by Application, 2023

Figure 95: Africa Clinical Trials Market Share (%), 2023

Table 01: Africa Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 02: Africa Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 03: Africa Clinical Trials Market Revenue (USD billion) Forecast, By Region, 2019–2032

Table 04: West Africa Clinical Trials Market Revenue (USD billion) Forecast, By Country/Sub-region, 2019–2032

Table 05: West Africa Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 06: West Africa Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 07: Senegal Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 08: Senegal Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 09: Mali Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 10: Mali Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 11: Burkina Faso Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 12: Burkina Faso Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 13: Cote d’Ivoire Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 14: Cote d’Ivoire Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 15: Ghana Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 16: Ghana Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 17: Gambia Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 18: Gambia Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 19: Nigeria Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 20: Nigeria Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 21: Rest of West Africa Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 22: Rest of West Africa Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 23: Central Africa Clinical Trials Market Revenue (USD billion) Forecast, By Country/Sub-region, 2019–2032

Table 24: Central Africa Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 25: Central Africa Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 26: Cameroon Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 27: Cameroon Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 28: Congo & DRC Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 29: Congo & DRC Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 30: Gabon Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 31: Gabon Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 32: Republic of Central Africa Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 33: Republic of Central Africa Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 34: Rest of Central Africa Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 35: Rest of Central Africa Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 36: East Africa Clinical Trials Market Revenue (USD billion) Forecast, By Country/Sub-region, 2019–2032

Table 37: East Africa Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 38: East Africa Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 39: Kenya Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 40: Kenya Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 41: Uganda Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 42: Uganda Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 43: Tanzania Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 44: Tanzania Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 45: Rest of East Africa Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 46: Rest of East Africa Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 47: South Africa Clinical Trials Market Revenue (USD billion) Forecast, By Country/Sub-region, 2019–2032

Table 48: South Africa Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 49: South Africa Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 50: Angola Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 51: Angola Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 52: South Africa Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 53: South Africa Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 54: Mozambique Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 55: Mozambique Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 56: Rest of South Africa Clinical Trials Market Revenue (USD billion) Forecast, By Phase, 2019–2032

Table 57: Rest of South Africa Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2019–2032

Africa Clinical Trials Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 203
Consulting Services
    How will you benefit from our consulting services ?